Lilly Moves Ahead With Retevmo Launch In A Challenging Environment

 
• By Jessica Merrill
FDA approved background, 3D rendering, blue street sign
Lilly will launch the RET inhibitor despite coronavirus-related limitations

More from New Products

More from Scrip